Fundic gland polyp

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Fundic gland polyp
Fundic gland polyp
Synonyms
Pronounce	N/A
Specialty	N/A
Symptoms	Often asymptomatic, may cause nausea or abdominal pain
Complications	Rarely gastric cancer
Onset
Duration
Types
Causes	Proton pump inhibitor use, familial adenomatous polyposis
Risks
Diagnosis	Endoscopy, biopsy
Differential diagnosis	Hyperplastic polyp, adenomatous polyp
Prevention
Treatment	Discontinuation of proton pump inhibitors, endoscopic surveillance
Medication
Prognosis	Generally benign
Frequency	Common in patients on long-term proton pump inhibitors
Deaths	N/A

[[File:Pie_chart_of_relative_incidences{{verify_spelling|Pie chart of relative incidences{{verify spelling|left|thumb]]

Histopathology of fundic gland polyp, high magnification, annotated

Histopathology of a fundic gland polyp with dysplasia

Fundic gland polyps (FGPs) are benign gastrointestinal lesions that arise in the stomach. They are the most common type of polyp found in the stomach and are often discovered incidentally during endoscopy procedures. FGPs are typically small, asymptomatic, and have a very low potential for becoming cancerous. However, their presence can sometimes be associated with certain medical conditions, such as Familial Adenomatous Polyposis (FAP) and the use of proton pump inhibitors (PPIs).

Etiology

The development of fundic gland polyps is believed to be influenced by both genetic and environmental factors. In individuals without familial syndromes, FGPs are often associated with prolonged use of PPIs, medications that reduce stomach acid production. In contrast, in patients with FAP, FGPs may develop due to genetic mutations.

Pathophysiology

Fundic gland polyps are characterized by the proliferation of the fundic gland epithelium. They are typically located in the fundus and body of the stomach, areas rich in acid-producing parietal cells. Despite their benign nature, the exact mechanism behind their formation is not fully understood but is thought to involve alterations in the regulation of cell growth within the stomach lining.

Clinical Features

Most patients with fundic gland polyps do not exhibit symptoms. When symptoms do occur, they are generally mild and can include dyspepsia (indigestion) or nonspecific gastrointestinal bleeding. FGPs are usually discovered incidentally during endoscopic examinations performed for other reasons.

Diagnosis

The diagnosis of fundic gland polyps is primarily made through endoscopy, where the characteristic appearance of these polyps can be visualized directly. Endoscopic findings typically show small, smooth, sessile polyps scattered throughout the fundus and body of the stomach. Confirmation of the diagnosis may require a biopsy, where histological examination reveals cystically dilated glands lined by flattened parietal and chief cells, without evidence of dysplasia.

Management

The management of fundic gland polyps depends on the patient's symptoms, the number and size of the polyps, and the presence of any associated conditions like FAP. In most cases, no treatment is necessary, and the polyps are simply monitored for changes over time. If polyps are associated with PPI use, discontinuation of the medication may be considered. In patients with FAP, regular surveillance is recommended due to the increased risk of gastrointestinal cancer.

Prognosis

The prognosis for individuals with fundic gland polyps is generally excellent, as these polyps rarely progress to cancer. However, in patients with FAP, there is a higher risk of developing gastrointestinal malignancies, necessitating regular monitoring.